Results Driven.

Trusted Advisors.

Alloush LLP is a corporate healthcare advisory firm strategically located in Washington, DC. The firm also has offices in New York and Boston and alliances with firms around the globe. Our main focus is in the biotechnology and pharmaceutical industry with a strong emphasis on emerging growth companies working on the development and commercialization of innovative technologies.


We strive to achieve a common goal with our clients - maximize growth while focusing on cost effective solutions for clients of all sizes and stages. Whether it comes to regulatory and compliance, commercial operations, business acquisitions or private equity,  we remain aligned with our clients interests, as well as on the cutting edge of new developments in healthcare, business, and technology to accelerate our clients place in the market. We understand the complexities of securing funding, safeguarding intellectual property, establishing strategic partnerships, bringing new products to market, opening up new revenue streams, and protecting existing product lines.

 

Clients consider us as their "go to advisors" for a multitude of matters because of our expertise, attentiveness, and focus on cost effectiveness. We pride ourselves on being a client centric firm. For nearly the last decade, this approach has allowed us to maintain the attention to detail needed while best serving our clients needs. And this philosophy is how our firm is able to maintain growth and success while building lasting business relationships. 

About our Firm

 

Featured Articles

Intellectual Property

Amgen's Biosimilar IP Win Was Wrong, Hospira Tells Fed. Circ.

Read the article

 

Eli Lilly throws SCOTUS hail mary in Cialis patent infringement fight

Read the article

Incyte's faithful Jakafi—and its sales force—are ready to roll with new indication

Read the article
 

‘One-and-done’ for new drugs could cut patent thickets and boost generic competition

Read the article

Mergers & Acquisitions

Pharma Catches Another Case Of M&A Fever

Read the article

 

What M&A Looks Like During the Pandemic

Read the article

Mereo BioPharma to merge with OncoMed Pharmaceuticals

Read the article
 

Merck Buys Tilos for Up to $773 Million to Expand Oncology Pipeline

Read the article

Celgene, Bristol-Myers set $2.2 billion termination fee for their mega deal

Read the article

Securitie

Getting to Know Reg A+: A Primer

Read the article

 

Simultaneous Offerings Under Rule 506(c) And Regulation S

Read the article

United States: Securities Law Considerations In Cross-Border Restructurings

Read the article

 

SEC Adopts Rules and Interpretations Related to Standards of Conduct for Broker-Dealers and Investment Advisers

Read the article

  • Grey LinkedIn Icon
  • Twitter

Contact Us          Careers          Disclaimer

© 2020 Alloush LLP